Oliver Gautschi
Oliver Gautschi
Unknown affiliation
Verified email at luks.ch
Title
Cited by
Cited by
Year
First-line crizotinib versus chemotherapy in ALK-positive lung cancer
BJ Solomon, T Mok, DW Kim, YL Wu, K Nakagawa, T Mekhail, E Felip, ...
N Engl j Med 371, 2167-2177, 2014
22192014
Lung Cancer That Harbors an HER2 Mutation: Epidemiologic Characteristics and Therapeutic Perspectives
J Mazieres, S Peters, B Lepage, AB Cortot, F Barlesi, M Beau-Faller, ...
Journal of clinical oncology 31 (16), 1997-2003, 2013
4732013
Aurora kinases as anticancer drug targets
O Gautschi, J Heighway, PC Mack, PR Purnell, PN Lara, DR Gandara
Clinical Cancer Research 14 (6), 1639-1648, 2008
4202008
Circulating deoxyribonucleic acid as prognostic marker in non–small-cell lung cancer patients undergoing chemotherapy
O Gautschi, C Bigosch, B Huegli, M Jermann, A Marx, E Chassé, ...
Journal of Clinical Oncology 22 (20), 4157-4164, 2004
2802004
Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort
J Mazières, G Zalcman, L Crinò, P Biondani, F Barlesi, T Filleron, ...
Journal of clinical oncology 33 (9), 992-999, 2015
2762015
Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open …
AT Shaw, TM Kim, L Crinò, C Gridelli, K Kiura, G Liu, S Novello, A Bearz, ...
The Lancet Oncology 18 (7), 874-886, 2017
2582017
Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation
O Gautschi, D Ratschiller, M Gugger, DC Betticher, J Heighway
Lung cancer 55 (1), 1-14, 2007
2372007
A novel bispecific antisense oligonucleotide inhibiting both bcl-2 and bcl-xL expression efficiently induces apoptosis in tumor cells
U Zangemeister-Wittke, SH Leech, RA Olie, AP Simões-Wüst, O Gautschi, ...
Clinical cancer research 6 (6), 2547-2555, 2000
2032000
Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins
O Gautschi, S Tschopp, RA Olie, SH Leech, AP Simoes-Wust, A Ziegler, ...
Journal of the National Cancer Institute 93 (6), 463-471, 2001
2022001
Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non–small-cell lung cancer: A model for assessing population-related pharmacogenomics
DR Gandara, T Kawaguchi, J Crowley, J Moon, K Furuse, M Kawahara, ...
Journal of clinical oncology 27 (21), 3540, 2009
1922009
Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial
M Pless, R Stupp, HB Ris, RA Stahel, W Weder, S Thierstein, MA Gerard, ...
The Lancet 386 (9998), 1049-1056, 2015
1802015
Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort
J Mazieres, F Barlesi, T Filleron, B Besse, I Monnet, M Beau-Faller, ...
Annals of Oncology 27 (2), 281-286, 2016
1512016
A patient with BRAF V600E lung adenocarcinoma responding to vemurafenib
O Gautschi, C Pauli, K Strobel, A Hirschmann, G Printzen, S Aebi, ...
Journal of Thoracic Oncology 7 (10), e23-e24, 2012
1462012
Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients
JL Ramirez, C Sarries, PL de Castro, B Roig, C Queralt, D Escuin, ...
Cancer letters 193 (2), 207-216, 2003
1452003
Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic …
SL Smith, NL Bowers, DC Betticher, O Gautschi, D Ratschiller, PR Hoban, ...
British journal of cancer 93 (6), 719-729, 2005
1442005
Induction of apoptosis in lung‐cancer cells following bcl‐xL anti‐sense treatment
SH Leech, RA Olie, O Gautschi, AP Simões‐Wüst, S Tschopp, R Häner, ...
International Journal of Cancer 86 (4), 570-576, 2000
1352000
Targeting RET in patients with RET-rearranged lung cancers: results from the global, multicenter RET registry
O Gautschi, J Milia, T Filleron, J Wolf, DP Carbone, D Owen, R Camidge, ...
Journal of Clinical Oncology 35 (13), 1403, 2017
1332017
Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international …
RA Stahel, O Riesterer, A Xyrafas, I Opitz, M Beyeler, A Ochsenbein, ...
The lancet oncology 16 (16), 1651-1658, 2015
1282015
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients
M Delaunay, J Cadranel, A Lusque, N Meyer, V Gounant, D Moro-Sibilot, ...
European Respiratory Journal 50 (2), 2017
1262017
Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II Trial …
T Ruhstaller, M Pless, D Dietrich, H Kranzbuehler, R von Moos, ...
Journal of clinical oncology 29 (6), 626-631, 2011
1232011
The system can't perform the operation now. Try again later.
Articles 1–20